Cell therapy weekly: more indications for Kymriah Member Exclusive NEWS ROUND-UP Latest news & views, Cell therapy Cell therapy weekly: more indications for Kymriah RegMedNet Jan 18, 2018
Kymriah and Yescarta recommended for EU approval Latest news & views, Spotlight on immunotherapy, UK and Europe, Cell therapy, CAR-T Kymriah and Yescarta recommended for EU approval RegMedNet Jul 03, 2018
Cell therapy weekly: Novartis faces production glitch over Kymriah NEWS ROUND-UP Latest news & views, Spotlight on immunotherapy, US and Canada, UK and Europe, Asia and the rest of the world, Cell therapy, FDA Cell therapy weekly: Novartis faces production glitch over Kymriah RegMedNet Jul 19, 2018
NICE approves Kymriah for use in adults following commercial agreement with NHS England Member Exclusive Latest news & views, Cell therapy, Ethics & policy NICE approves Kymriah for use in adults following commercial agreement with NHS England Freya Leask Feb 01, 2019
Kymriah is first CAR-T therapy to be made available on the NHS Spotlight on immunotherapy, Cell therapy, CAR-T, Ethics & policy Kymriah is first CAR-T therapy to be made available on the NHS RegMedNet Sep 05, 2018
Cell therapy weekly: Kymriah could be available in Japan and stem cells show benefits against multiple sclerosis NEWS ROUND-UP Latest news & views, Spotlight on immunotherapy, US and Canada, UK and Europe, Asia and the rest of the world, Basic research, Cell therapy, Clinical trials, CAR-T Cell therapy weekly: Kymriah could be available in Japan and stem cells show benefits against multiple sclerosis RegMedNet Apr 26, 2018
Cell therapy weekly: Yescarta “is not recommended” for NHS availability Member Exclusive US and Canada, UK and Europe, Cell therapy, CAR-T, Ethics & policy, Industry developments Cell therapy weekly: Yescarta “is not recommended” for NHS availability RegMedNet Aug 30, 2018
Cell therapy weekly: New hurdle in immunotherapy development Member Exclusive NEWS ROUND-UP Spotlight on immunotherapy, Basic research, Cell therapy, Ethics & policy Cell therapy weekly: New hurdle in immunotherapy development RegMedNet Sep 20, 2018
Cell therapy weekly: New biotech focused on engineered cells licenses Harvard tech Member Exclusive NEWS ROUND-UP Latest news & views, US and Canada, Asia and the rest of the world, Cell therapy, Manufacturing & scale-up, CAR-T Cell therapy weekly: New biotech focused on engineered cells licenses Harvard tech RegMedNet Mar 27, 2019
Cenk Sumen (Thermo Fisher Scientific) on the 'durability' of cell & gene therapies Cenk Sumen (Thermo Fisher Scientific) on the 'durability' of cell & gene therapies Shiraz Ziya Sep 03, 2018
Welcome to our spotlight on immunotherapy! Spotlight on immunotherapy Welcome to our spotlight on immunotherapy! RegMedNet Sep 01, 2018
Shanghai venture will bring advanced cell therapies to China Upcoming & past events Shanghai venture will bring advanced cell therapies to China Freya Leask Sep 28, 2018
Industry updates with Dusko Ilic: August 2019 Industry developments Industry updates with Dusko Ilic: August 2019 Dusko ILIC Nov 12, 2019
ASGCT 2019: editor's picks Cell therapy, CAR-T, Upcoming & past events ASGCT 2019: editor's picks Freya Leask Mar 25, 2019
3 years of RegMedNet - with Freya Leask INTERVIEW CAR-T, FDA, Upcoming & past events, RegMedNet 3 years of RegMedNet - with Freya Leask RegMedNet Dec 17, 2019
NHS England strikes deal for ground-breaking CAR-T therapy in a new European first Member Exclusive Latest news & views, Cell therapy, Ethics & policy NHS England strikes deal for ground-breaking CAR-T therapy in a new European first Jasmine Harris Oct 08, 2018
Cell therapy weekly: StemGenex receives warning letter from FDA over unapproved cell therapy and facility with “significant violations” Member Exclusive NEWS ROUND-UP Cell therapy, Clinical trials, Ethics & policy Cell therapy weekly: StemGenex receives warning letter from FDA over unapproved cell therapy and facility with “significant violations” RegMedNet Nov 15, 2018
The Cell Manufacturing Imperative Member Exclusive COMMUNITY POST Latest news & views, Spotlight on commercialization and translation, Cell therapy, Manufacturing & scale-up The Cell Manufacturing Imperative RegMedNet Oct 19, 2017
Novel CAR T-cell therapy removes the risk of severe side effects Member Exclusive Latest news & views, US and Canada, CAR-T Novel CAR T-cell therapy removes the risk of severe side effects Mike Gregg Apr 30, 2019
Cell therapy special: best of 2018 Member Exclusive NEWS ROUND-UP Latest news & views, US and Canada, UK and Europe, Asia and the rest of the world, Gene editing, Cell therapy Cell therapy special: best of 2018 RegMedNet Dec 13, 2018
